Attention, behavioral, and educational adaptation disorders in children with childhood absence epilepsy

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. In children with epilepsy, the prevalence of comorbid conditions, including neuropsychological disorders, is significantly higher than in the general population of healthy peers. Among the most common comorbid conditions are attention-deficit/hyperactivity disorder, as well as affective and anxiety disorders. According to various studies, these comorbid disturbances exert a substantial impact on cognitive functioning, social adaptation, and quality of life in patients with epilepsy.

Aim. To conduct a comprehensive analysis of attention deficits and behavioral control impairments in children and adolescents with childhood absence epilepsy (CAE) and to determine their contribution to academic maladaptation and quality of life outcomes.

Materials and methods. To achieve the study objective, follow-up data from 70 patients with CAE (including those presenting with active absence seizures, those attending scheduled follow-up consultations, and patients in stable medication-induced remission) and 34 healthy volunteers were analyzed. Academic performance in both the study and control groups was assessed based on final grades in core school subjects and was used as an objective indicator of educational adaptation. Quality of life was evaluated using the Pediatric Quality of Life Inventory 4.0, with age-appropriate versions for children aged 8–12 and 13–18 years. A psychiatrist participated in the study to conduct clinical assessments. Electroencephalographic recordings were performed using the standard “10–20” international electrode placement system.

Results. A high prevalence of attention and behavioral regulation disturbances consistent with attention-deficit/hyperactivity disorder symptomatology was identified in children and adolescents with CAE. Academic performance in patients with CAE was lower compared to healthy peers, and the presence of comorbid attention-deficit/hyperactivity disorder was associated with a tendency toward further decline in educational outcomes. Quality of life in children and adolescents with CAE was predominantly reduced in the psychosocial and school functioning domains; these impairments persisted regardless of therapeutic status, indicating the stable nature of the identified disturbances.

Conclusion. The findings indicate that CAE is associated with a complex pattern of cognitive and behavioral disturbances, including attention deficits, difficulties in behavioral control, and impairments in social-communicative functioning. These alterations are reflected in reduced academic performance and lower quality of life scores. Importantly, even after achieving remission, children may continue to experience difficulties in interpersonal interactions and school integration, suggesting the persistent nature of these impairments and underscoring the need for comprehensive management extending beyond seizure control.

About the authors

A. A. Dubrovskaya

Moscow Multidisciplinary Clinical Center “Kommunarka”, Moscow Healthcare Department; Russian University of Medicine, Ministry of Health of Russia

Email: vpn_neuro@mail.ru
ORCID iD: 0009-0009-4173-8785

Department of Neurology, Faculty of Medicine, Scientific and Educational Institute of Clinical Medicine named after N.A. Semashko

Russian Federation, Build. 2, 8 Sosenskiy Stan St., Kommunarka Settlement, Moscow 108814; 4 Dolgorukovskaya St., Moscow 127006

Pavel N. Vlasov

Russian University of Medicine, Ministry of Health of Russia

Author for correspondence.
Email: vpn_neuro@mail.ru
ORCID iD: 0000-0001-8321-5864

Department of Neurology, Faculty of Medicine, Scientific and Educational Institute of Clinical Medicine named after N.A. Semashko

Russian Federation, 4 Dolgorukovskaya St., Moscow 127006

References

  1. Pylaeva O.A., Shatenshtein A.A., Mukhin K.Yu. Attention-deficit/hyperactivity disorder: comorbidities, with emphasis on association with epilepsy. Russkiy zhurnal detskoy nevrologii = Russian Journal of Child Neurology 2018;13(3):57–74. (In Russ.).
  2. Useinova A.N., Egorova E.A., Maryanenko S.P. Attention-deficit/hyperactivity disorder: current diagnostic and therapeutic options. Psikhiatriya = Psychiatry 2023;21(4):72–85. (In Russ.).
  3. Caplan R., Siddarth P., Stahl L. et al. Childhood absence epilepsy: behavioral, cognitive, and linguistic comorbidities. Epilepsia 2008;49:1838–46. doi: 10.1111/j.1528-1167.2008.01680.x
  4. Cortese S. Evidence-based prescribing of medications for ADHD: where are we in 2023? Expert Opin Pharmacother 2023;24(4):425–34. doi: 10.1080/14656566.2023.2169604
  5. D’Agati Е., Cerminara C., Casarelli L. et al. Attention and executive functions profile in childhood absence epilepsy. Brain Dev 2012;34(10):812–7. doi: 10.1016/j.braindev.2012.03.001.
  6. Danckaerts M., Sonuga-Barke E.J., Banaschewski T. et al. The quality of life of children with attention deficit/hyperactivity disorder: a systematic review. Eur Child Adolesc Psychiatry 2010;19(2):83–105. doi: 10.1007/s00787-009-0046-3
  7. Ferretti N.M., King S.L., Hilton D.C. et al. Social functioning in youth with attention-deficit/hyperactivity disorder and sluggish cognitive tempo. Yale J Biol Med 2019;92(1):29–35.
  8. Glauser T.A., Cnaan A., Shinnar S. et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med 2010;362(9):790–9. doi: 10.1056/NEJMoa0902014
  9. He Z., Yang X., Yumei Li Y. et al. Attention-deficit/hyperactivity disorder in children with epilepsy: a systematic review and meta-analysis of prevalence and risk factors. Epilepsia Open 2024;9(4):1148–65. doi: 10.1002/epi4.12939
  10. I-Ching С., Chang Y., Chin Z. et al. Correlation between epilepsy and attention deficit hyperactivity disorder: a population-based cohort study. PLoS One 2013;8(3):e57926. doi: 10.1371/journal.pone.0057926
  11. Kooij J.J.S., Bijlenga D., Salerno L. et al. Updated European Consensus Statement on diagnosis and treatment of adult ADHD. Eur Psychiatry 2019;56:14–34. doi: 10.1016/j.eurpsy.2018.11.001
  12. Salari N., Ghasemi H., Abdoli N. et al. The global prevalence of ADHD in children and adolescents: a systematic review and meta-analysis. Ital J Pediatr 2023;49(1):48. doi: 10.1186/s13052-023-01456-1
  13. Terán P.A. Attention-deficit/hyperactivity disorder and substance abuse. Scientific evidence. Medicina 2020;80(2):76–79.
  14. Uliel-Sibony S., Chernuha V., Latzer I.T., Leitner Y. Epilepsy and attention-deficit/hyperactivity disorder in children and adolescents: an overview of etiology, prevalence, and treatment. Front Hum Neurosci 2023;17:1021605. doi: 10.3389/fnhum.2023.1021605
  15. Wanni A. S.d., Badloe N., Sciberras E. et al. The impact of childhood ADHD on HRQoL: systematic review and meta-analysis. J Attention Disord 2023;27(6):598–611. doi: 10.1177/10870547231155438

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2026 ABV-Press

License URL: https://rjdn.abvpress.ru/jour/about/editorialPolicies

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-90927 от  13.02.2026.